PURPOSE: To describe a novel surgical technique for revision of deep sclerectomy surgery in nanophthalmic uveal effusion syndrome. METHODS: A 46-year-old woman with recessively inherited nanophthalmos and chronic uveal effusions underwent a revision of previous failed deep sclerectomy surgery. In the presence of scar tissue, revision of sclerectomies was greatly facilitated by the use of a Kelly scleral punch (Katena Products, Inc., Denville, NJ, USA). To inhibit further scarring, mitomycin-C (MMC) was applied topically in each quadrant posterior to the equator. RESULTS: The scleral punch allowed outward scleral dissection from the suprachoroidal space, and brisk enlargement of sclerectomies in all quadrants without perforation of choroidal tissue. Post-operative conjunctival wound healing appeared unimpeded by the posteriorly placed MMC sponges. Near-total resolution of the effusions had occurred by 3 months. CONCLUSIONS: The scleral punch provides a safe and effective method for constructing and revising full-thickness sclerectomies in the nanophthalmic eye, minimizing the risk of choroidal trauma. The use of topical MMC may reduce the risk of late failure of trans-scleral outflow due to fibrosis.
PURPOSE: To describe a novel surgical technique for revision of deep sclerectomy surgery in nanophthalmic uveal effusion syndrome. METHODS: A 46-year-old woman with recessively inherited nanophthalmos and chronic uveal effusions underwent a revision of previous failed deep sclerectomy surgery. In the presence of scar tissue, revision of sclerectomies was greatly facilitated by the use of a Kelly scleral punch (Katena Products, Inc., Denville, NJ, USA). To inhibit further scarring, mitomycin-C (MMC) was applied topically in each quadrant posterior to the equator. RESULTS: The scleral punch allowed outward scleral dissection from the suprachoroidal space, and brisk enlargement of sclerectomies in all quadrants without perforation of choroidal tissue. Post-operative conjunctival wound healing appeared unimpeded by the posteriorly placed MMC sponges. Near-total resolution of the effusions had occurred by 3 months. CONCLUSIONS: The scleral punch provides a safe and effective method for constructing and revising full-thickness sclerectomies in the nanophthalmic eye, minimizing the risk of choroidal trauma. The use of topical MMC may reduce the risk of late failure of trans-scleral outflow due to fibrosis.
Authors: Timothy L Jackson; Ali Hussain; Ana M S Morley; Paul M Sullivan; Andrea Hodgetts; Austen El-Osta; Jost Hillenkamp; Stephen J Charles; Richard Sheard; Tom H Williamson; Anupma Kumar; D Alistair H Laidlaw; W Hong Woon; Mark J Costen; Andrew J Luff; John Marshall Journal: Invest Ophthalmol Vis Sci Date: 2008-06-14 Impact factor: 4.799
Authors: M I Othman; S A Sullivan; G L Skuta; D A Cockrell; H M Stringham; C A Downs; A Fornés; A Mick; M Boehnke; D Vollrath; J E Richards Journal: Am J Hum Genet Date: 1998-11 Impact factor: 11.025
Authors: M Uyama; K Takahashi; J Kozaki; N Tagami; Y Takada; H Ohkuma; H Matsunaga; T Kimoto; T Nishimura Journal: Ophthalmology Date: 2000-03 Impact factor: 12.079
Authors: Shuhei Kameya; Norman L Hawes; Bo Chang; John R Heckenlively; Jürgen K Naggert; Patsy M Nishina Journal: Hum Mol Genet Date: 2002-08-01 Impact factor: 6.150
Authors: Olof H Sundin; Sharola Dharmaraj; Imran A Bhutto; Takuya Hasegawa; D Scott McLeod; Carol A Merges; Eduardo D Silval; Irene H Maumenee; Gerard A Lutty Journal: Ophthalmic Genet Date: 2008-03 Impact factor: 1.803
Authors: Carol L Shields; Kelsey Roelofs; Maura Di Nicola; Kareem Sioufi; Arman Mashayekhi; Jerry A Shields Journal: Indian J Ophthalmol Date: 2017-11 Impact factor: 1.848